Beijing Aosaikang Pharmaceutical Co., Ltd. (002755)
XSHE XSHE Primary Summary
002755 Chart
People also search for
Beijing Aosaikang Pharmaceutical Co., Ltd. (002755) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Beijing Aosaikang Pharmaceutical Co., Ltd. ever had a stock split?
Beijing Aosaikang Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jingfei Ma CEO | XSHE Exchange | CNE100001X92 ISIN |
| CN Country | 988 Employees | 18 Jun 2026 Last Dividend | 31 May 2018 Last Split | - IPO Date |
Overview
Beijing Aosaikang Pharmaceutical Co., Ltd. is a distinguished entity in the pharmaceutical sector, primarily engaged in the research, development, manufacturing, marketing, and sale of pharmaceuticals, fine chemicals, and health-care products within the Chinese market. Established in 2003, the company has been dedicated to addressing diverse health concerns through its comprehensive range of products, leveraging advanced technology and research capabilities. Located in Nanjing, China, Aosaikang Pharmaceutical has carved a niche for itself, especially in the realms of digestive health, oncology, and antibiotic treatments, marking a significant footprint in the healthcare industry.
Products and Services
- Proton Pump Inhibitor Injections
These injections are formulated to effectively reduce stomach acid production, thereby providing relief from conditions such as gastroesophageal reflux disease (GERD), stomach ulcers, and Zollinger-Ellison Syndrome. They are a testament to Aosaikang's commitment to addressing digestive health issues with innovative approaches.
- Oncology Medicines
Aosaikang offers a comprehensive range of medicines aimed at treating various types of cancer, reflecting the company's dedication to advancing cancer treatment and improving patient outcomes. Their oncology portfolio emphasizes targeted therapies and innovative treatment solutions.
- Active Pharmaceutical Ingredients (APIs)
The company also specializes in the production of high-quality APIs, which serve as essential components for a wide range of medicines. This not only enables Aosaikang to maintain control over the quality and supply of its products but also positions the company as a key player in the global pharmaceutical supply chain.
- Products in Digestive, Oncology, Antibiotic, and Other Areas
In addition to the specific products mentioned, Beijing Aosaikang Pharmaceutical Co., Ltd. provides a broad spectrum of products covering digestive health, oncology, antibiotic treatments, and more. This diverse product range is geared towards meeting the varied health care needs of the population, reinforcing the company’s role in promoting health and wellbeing.
